Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)

por Mastrorosa, Ilaria, Gagliardini, Roberta, Segala, Francesco Vladimiro, Mondi, Annalisa, Lorenzini, Patrizia, Cerva, Carlotta, Taddei, Eleonora, Bai, Francesca, Vergori, Alessandra, Marcantonio, Negri, Pinnetti, Carmela, Cicalini, Stefania, Murri, Rita, Mazzotta, Valentina, Camici, Marta, Mosti, Silvia, Bini, Teresa, Maffongelli, Gaetano, Beccacece, Alessia, Milozzi, Eugenia, Iannetta, Marco, Lamonica, Silvia, Fusto, Marisa, Plazzi, Maria Maddalena, Ottou, Sandrine, Lichtner, Miriam, Fantoni, Massimo, Andreoni, Massimo, Sarmati, Loredana, Cauda, Roberto, Girardi, Enrico, Nicastri, Emanuele, D'Arminio Monforte, Antonella, Palmieri, Fabrizio, Cingolani, Antonella, Vaia, Francesco, Antinori, Andrea
Publicado 2023